13F-HR filed by a16z Capital Management, L.L.C.
a16z Capital Management, L.L.C. filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 21:10:11 UTC, with 24 holding rows worth $19,893,100,531.
- Accession
- 0001540358-26-000014
- Filer
- CIK 1540358
- Filed
- 2026-11-16
- Accepted by EDGAR
- Ingested
- Source
- EDGAR daily index
13F report for Q3 2026
A holdings report, 24 entries on the cover page, a total value of $19,893,100,531 stated on the cover page (in dollars after the unit check, H1), rows summing to $19,893,100,531 with VALUE read as dollars as filed, 13F file number 028-23922. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SPACE EXPLORATION TECHN CORP CLASS A COM STK | 84615Q103 | Stock | 121,777,808 | $18,371,400,115 | dollars as filed | |
| NAVAN INC CL A | 639193101 | Stock | 28,218,676 | $592,310,009 | dollars as filed | |
| Braveheart Bio Inc | 10567X101 | COM | 10,232,420 | $206,694,884 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 782,934 | $160,705,033 | dollars as filed | |
| FREENOME INC | 35661P100 | COMMON STOCK | 5,571,599 | $87,752,684 | dollars as filed | |
| Neutron Holdings Inc | 64125S104 | Common / Ordinary Stock | 2,849,097 | $80,259,062 | dollars as filed | |
| BLOCK INC CL A | 852234103 | Stock | 1,016,697 | $74,757,730 | dollars as filed | |
| SCRIBE THERAPEUTIC COM | 811033109 | COM | 3,082,725 | $56,737,554 | dollars as filed | |
| FIGMA INC CL A | 316841105 | COM | 2,565,731 | $53,931,666 | dollars as filed | |
| MAZE THERAPEUTICS INC COM | 578784100 | Stock | 1,702,225 | $46,266,476 | dollars as filed | |
| STANDARD NUCLEAR INC | 853678100 | COM CL A | 2,924,890 | $34,542,951 | dollars as filed | |
| DAMORA THERAPEUTICS INC | 36322Q206 | COMMON STOCK | 1,236,157 | $26,305,421 | dollars as filed | |
| BIOAGE LABS INC COM | 09077V100 | Stock | 3,233,170 | $22,923,175 | dollars as filed | |
| ERASCA INC COM | 29479A108 | Stock | 1,431,250 | $20,982,125 | dollars as filed | |
| META PLATFORMS INC CL A | 30303M102 | COM | 20,951 | $15,193,246 | dollars as filed | |
| ROBLOX CORP CL A | 771049103 | Stock | 274,570 | $11,633,531 | dollars as filed | |
| CAMP4 THERAPEUTICS CORP | 13463J101 | COM | 2,125,339 | $8,586,370 | dollars as filed | |
| AKTIS ONCOLOGY INC | 01021M104 | COMMON STOCK | 415,000 | $8,080,050 | dollars as filed | |
| BITGO HOLDINGS INC-CL A | 091947101 | COM SHS CL A | 666,356 | $4,931,034 | dollars as filed | |
| NAUTILUS BIOTECHNOLOGY INC | 63909J108 | COM | 2,656,655 | $3,772,450 | dollars as filed | |
| BLOSSOMHILL THERAPEUTICS INC | 095130100 | COM | 125,000 | $2,330,000 | dollars as filed | |
| KAILERA THERAPEUTICS INC | 482931102 | COMMON STOCK | 140,000 | $1,598,800 | dollars as filed | |
| GINKGO BIOWORKS HOLDINGS INC | 37611X209 | COMMON STOCK | 108,568 | $1,392,927 | dollars as filed | |
| IP STRATEGY HOLDINGS INC | 42727R302 | COM | 4,137 | $13,238 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001540358-26-000014 | this filing | 2026-11-16 |